Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, Inc. (ORKA), sold 10,019 shares at $91.11 ($926K) on 2026-09-11, disclosed to the SEC on 2026-09-15.
Scheduled sale ($926k) by Senior Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.11 | 3,000 | $273K | 29.5% |
| 2 | $92.41 | 4,051 | $374K | 40.4% |
| 3 | $93.26 | 2,208 | $206K | 22.2% |
| 4 | $94.02 | 200 | $19K | 2.0% |
| 5 | $95.71 | 560 | $54K | 5.8% |
| Total | $92.43 avg | 10,019 |
| $926K |
| 100% |
| Filing → |
| ORKA | SELL | 2026-08-14 | $1.1M | — | Filing → |
| ORKA | SELL | 2026-07-13 | $846K | — | Filing → |
| ORKA | SELL | 2026-06-22 | $128K | — | Filing → |